Identifying the links between obesity, insulin resistance and β-cell function:: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes

被引:229
作者
Greenberg, AS
McDaniel, ML [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[3] Tufts Univ New England Med Ctr, Tupper Res Inst, Div Endocrinol, Boston, MA 02111 USA
关键词
diabetes mellitus type 2; PPAR gamma; tumour necrosis factor-alpha; pathogenesis;
D O I
10.1046/j.1365-2362.32.s3.4.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A combination of insulin resistance and pancreatic beta-cell dysfunction underlies most cases of type 2 diabetes. While the interplay of these two impairments is believed to be important in the development and progression of type 2 diabetes, the mechanisms involved are unclear. A number of factors have been suggested as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of type 2 diabetes mellitus. Pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) have deleterious effects on both glucose homeostasis and beta-cell function, and can disrupt insulin signalling pathways in both pancreatic beta cells and liver and adipose tissue. The anti-inflammatory activity of the thiazolidinedione anti-diabetic agents is potentially beneficial, given the possible role of pro-inflammatory cytokines in linking insulin resistance with beta-cell dysfunction.
引用
收藏
页码:24 / 34
页数:11
相关论文
共 121 条
[11]   Nitric oxide and cellular respiration [J].
Brunori, M ;
Giuffrè, A ;
Sarti, P ;
Stubauer, G ;
Wilson, MT .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 56 (7-8) :549-557
[12]   Response of pancreatic β-cells to improved insulin sensitivity in women at high risk for type 2 diabetes [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Berkowitz, K ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Azen, SP .
DIABETES, 2000, 49 (05) :782-788
[13]   Peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats [J].
Buckingham, RE ;
Al-Barazanji, KA ;
Toseland, CDN ;
Slaughter, M ;
Connor, SC ;
West, A ;
Bond, B ;
Turner, NC ;
Clapham, JC .
DIABETES, 1998, 47 (08) :1326-1334
[14]   INTERFERON-GAMMA - PLEIOTROPIC EFFECTS ON A RAT PANCREATIC BETA-CELL LINE [J].
CAMPBELL, IL ;
OXBROW, L ;
HARRISON, LC .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1987, 52 (1-2) :161-167
[15]   IMPACT OF OBESITY ON INSULIN ACTION IN VOLUNTEERS WITH NORMAL GLUCOSE-TOLERANCE - DEMONSTRATION OF A THRESHOLD FOR THE ADVERSE EFFECT OF OBESITY [J].
CAMPBELL, PJ ;
GERICH, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :1114-1118
[16]  
Carey DG, 2000, DIABETOLOGIA, V43, pA68
[17]   CLINICAL REVIEW .26. INSULIN RESISTANCE IN OBESE AND NONOBESE MAN [J].
CARO, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (04) :691-695
[18]   ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[19]   Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance [J].
Cavaghan, MK ;
Ehrmann, DA ;
Byrne, MM ;
Polonsky, KS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :530-537
[20]   Interactions between insulin resistance and insulin secretion in the development of glucose intolerance [J].
Cavaghan, MK ;
Ehrmann, DA ;
Polonsky, KS .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (03) :329-333